National Health Investors, Inc. (NHI) Market Cap & Valuation Ratios
National Health Investors, Inc. (NHI) has a market cap of $3.3B, a trailing P/E of 19.4 and a price-to-sales ratio of 7.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NHINational Health Investors, Inc.Follow NHI — free
—
Price chart with a free account
- Market cap
- 3.3B
- P/E TTM
- 19.4
- Dividend yield
- 5.5%
- 52-week
- —
- Next earnings
- 9 Nov, in 14 days
Peers
reit - healthcare facilities · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | EV/EBITDA | P/B | Div. yield | Rev. growth | Op. margin |
|---|---|---|---|---|---|---|
| NHI | 3.3 | 14.4 | 2.10 | 5.5% | +24% | 52% |
| OHI | 14 | 12.5 | 2.60 | 5.8% | +15% | 87% |
| DOC | 13 | 11.5 | 1.69 | 6.3% | +6% | 27% |
| AHR | 12 | 17.7 | 3.13 | 1.9% | +16% | 19% |
| CTRE | 8.7 | 18.6 | 1.93 | 4.0% | +53% | 72% |
| HR | 6.2 | 16.5 | 1.46 | 5.3% | -6% | 9% |
| SBRA | 5.0 | 18.8 | 1.82 | 6.1% | +17% | 21% |
| LTC | 2.4 | 11.8 | 1.86 | 5.2% | +60% | 63% |
| DHC | 1.9 | 26.3 | 1.20 | 0.5% | -1% | -6% |
| MPT | 1.6 | 13.9 | 0.36 | 13.0% | +11% | 49% |
| NHP | 1.1 | 21.0 | 1.07 | — | -1% | 3% |
| Median of these 10 | 17.1 | 1.75 | 5.3% | +13% | 24% |
; P/B 2.10 vs. 1.75. NHI's own P/E sits at the 11th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesDOC and HR and DHC and MPT and NHP have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
National Health Investors, Inc. — questions
- What is National Health Investors, Inc.'s market cap?
- $3.3B.
- What is National Health Investors, Inc.'s P/E ratio?
- 19.4 on trailing twelve-month earnings to 2026-06-30.
- What is National Health Investors, Inc.'s price-to-sales ratio?
- 7.6.
Every figure on this page comes from National Health Investors, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.